Flavopiridol: a promising cyclin-dependent kinase inhibitor in cancer treatment.
Baghel US, Kriplani P, Patel NM, Kaur M, Sharma K, Meghani M, Sharma A, Singh D, Singh B, Setzer WN, Sharifi-Rad J, Calina D.
Baghel US, et al. Among authors: kaur m.
Naunyn Schmiedebergs Arch Pharmacol. 2024 Nov 26. doi: 10.1007/s00210-024-03599-2. Online ahead of print.
Naunyn Schmiedebergs Arch Pharmacol. 2024.
PMID: 39589530
Review.